NCT07847099Not yet recruiting
Platelet Indices and Blood Groups in Type 2 Diabetes Vascular Complications
Association of Platelet Indices and Blood Groups With Vascular Complications in Patients With Type 2 Diabetes Mellitus
Source: ClinicalTrials.gov · Last updated 29 Sept 2026
Brief summary (registry, in English)
This cross-sectional study aims to evaluate the association of platelet indices and ABO blood groups with vascular complications in patients with type 2 diabetes mellitus.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 23 Sept 2026
- Start date
- 26 Sept 2026
- Primary completion date
- 26 Sept 2027
- Lead sponsor
- Assiut University
- Diseases
- Type 2 diabetes
- NCT number
- NCT07847099
What you commit to
- Study type: Observational
- Planned participants: 100
- From 26 Sept 2026 to the primary completion date, 26 Sept 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current anticoagulant or antiplatelet therapy
- Recent major surgery or trauma
Other illness
- Type 1 diabetes mellitus
- Gestational diabetes
- Acute infection or sepsis
- Malignancy
- Chronic liver disease
- Autoimmune diseases
Lab values
- Hematological disorders affecting platelet count or function
Other
- Pregnancy
Who the study is looking for
- Age 18 years or older
- Confirmed diagnosis of type 2 diabetes mellitus according to ADA criteria
- Written informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.